Prediction of vulnerability to bipolar disorder using multivariate neurocognitive patterns: a pilot study

Area of Science:

• Neuroscience
• Psychiatry
• Biomarker Discovery

Background:

• Bipolar disorder (BD) is a prevalent mental health condition with a high rate of recurrence.
• Accurate, objective biomarkers are needed for individual-level identification of BD patients.
• Existing diagnostic methods lack sufficient objectivity and individual specificity.

Purpose of the Study:

• To evaluate the potential of neurocognitive signatures as objective biomarkers for bipolar disorder.
• To assess the ability of these signatures to differentiate BD patients from healthy controls.
• To determine if neurocognitive signatures can identify at-risk individuals, such as siblings of BD patients.

Main Methods:

• Utilized the affective Go/No-go task and the Cambridge Gambling task to assess neurocognitive performance.
• Applied these tasks to cohorts of bipolar disorder patients and healthy controls.
• Validated findings across two independent cohorts to assess generalizability.

Main Results:

• Neurocognitive signatures demonstrated significant potential in distinguishing individuals with bipolar disorder from healthy controls.
• These signatures were also effective in identifying siblings of BD patients.
• The observed neurocognitive patterns were replicable across independent cohorts, suggesting generalizability.

Conclusions:

• Neurocognitive signatures show promise as objective biomarkers for bipolar disorder.
• These findings support the potential for using neurocognitive assessments in clinical settings for BD identification and risk assessment.
• Future research should explore integrating neurocognitive data with other biological markers for enhanced diagnostic accuracy.